System and method for atomizing and monitoring a drug cartridge during inhalation treatments
An atomizer includes a cartridge with a reservoir containing a fluid and a heating system configured to atomize the fluid into a vapor for inhalation. A respiratory indicator is configured to determine an inhalation period and an exhalation period of a patient using the atomizer. The atomizer then increases atomization of the vapor during the inhalation period and decreases atomization of the vapor during the exhalation period. An impedance sensor measures an amount of the fluid in the atomizer and deactivates atomization in response to an indication of a low fluid level.
1. An atomizer, comprising:
a cartridge configured to hold a fluid;
an atomizer system configured to atomize the fluid in the cartridge into a vapor for inhalation;
a biosensor including a sensor circuit that emits a first wavelength of light at tissue of a user and generates at least a first spectral response around the first wavelength of light reflected from the tissue of the user; and
a processing circuit configured to:
determine a respiration rate of the user using the first spectral response;
determine an inhalation period and exhalation period from the respiration rate; and
control the atomizer system to increase atomization of the vapor during the inhalation period and decrease atomization of the vapor during the exhalation period.
2. The atomizer of claim 1 , wherein the atomizer further comprises:
a fluid sensor configured to detect an indicator of an amount of fluid in the cartridge; and
wherein the processing circuit is further configured to:
determine the indicator of the amount of fluid in the cartridge reaches a predetermined level; and
deactivate the atomizer system in response to the indicator of the amount of fluid in the cartridge reaching the predetermined level.
3. The atomizer of claim 2 , wherein the atomizer system comprises:
a wick for absorbing fluid in the cartridge; and
a heating element in contact with the wick, wherein the heating element increases in heat to atomize the fluid absorbed by the wick.
4. The atomizer of claim 3 , wherein the fluid sensor comprises:
an impedance sensor configured to detect an impedance of the wick using the heating element.
5. The atomizer of claim 4 , wherein the processing circuit is further configured to control the atomizer to operate in an atomization mode or a measurement mode by:
activating the atomization system to operate in the atomization mode to atomize the fluid in the cartridge into a vapor for inhalation using the heating element;
deactivate the atomization system; and
activate the impedance sensor to detect an impedance of the wick using the heating element.
6. The atomizer of claim 1 , wherein the processing circuit is further configured to:
determine vitals of the user using at least the first spectral response, wherein the vitals include one or more of: respiratory rate, heart rate or blood pressure;
determine a concentration of a substance in blood flow of vessels of the patient using at least the first spectral response, wherein the substance increases in concentration in the blood flow of the vessels in response to inhalation of the vapor; and
control the atomizer system to increase atomization of the vapor or decrease atomization of the vapor in response to the concentration level of the substance in the blood flow.
7. The atomizer of claim 6 , wherein the sensor circuit is further configured to:
generate the first spectral response around the first wavelength of light reflected from the tissue of the user;
generate at least a second spectral response around a second wavelength of light reflected from the tissue of the user; and
wherein the processing circuit is further configured to:
obtain a value L λ1 using the first spectral response, wherein the value L λ1 isolates the first spectral response due to pulsating blood flow;
obtain a value L λ2 using the second spectral response, wherein the value L λ2 isolates the second spectral response due to pulsating blood flow;
obtain a value R λ1,λ2 from a ratio of the value L λ1 and the value L λ2 ;
determine the concentration level of the substance in the blood flow from the value R λ1,λ2 .
8. The atomizer of claim 7 , wherein the concentration level of the substance includes at least one of: a blood nicotine level, a liver enzyme level, or a nitric oxide (NO) indicator level.
9. The atomizer of claim 8 , wherein the atomizer is configured to alter a dosage, an administration rate or an administration period of the fluid in response to the concentration level of the substance in the blood flow.
10. The atomizer of claim 1 , wherein the cartridge includes:
a chamber between a wick and a port of the cartridge, wherein the chamber is configured to hold the fluid; and
a heat soluble seal formed between the chamber and the wick, wherein the heat soluble seal comprises a material configured to dissolve upon heating of the wick.
11. The atomizer of claim 1 , wherein the cartridge includes:
a first set of baffles extending across a mouthpiece;
a second set of baffles extending across air flow channels, wherein the air flow channels prove air into the cartridge; and
wherein the first set of baffles and the second set of baffles form an air flow chamber configured to enhance mixing of the vapor and air.
12. An atomizer, comprising:
a cartridge configured to hold a fluid;
an atomizer system configured to atomize the fluid in the cartridge into a vapor for inhalation, wherein the atomizer system includes:
a wick for absorbing fluid in the cartridge; and
a heating element in contact with the wick, wherein the heating element increases in heat to atomize the fluid absorbed by the wick;
an impedance sensor configured to detect an indicator of an amount of fluid in the cartridge, wherein the impedance sensor is configured to detect an impedance of the wick using the heating element; and
a processing circuit configured to:
activate the atomization system to operate in the atomization mode to atomize the fluid in the cartridge into a vapor using the heating element;
deactivate the atomization system; and
activate the impedance sensor to detect the impedance of the wick using the heating element.
13. The atomizer of claim 12 , wherein the processing circuit is further configured to:
obtain an initial impedance of the wick prior to a first atomization mode;
determine the initial impedance is within a predetermined range of impedance measurements; and
initiate the first atomization mode.
14. The atomizer of claim 12 , wherein the processing circuit is further configured to:
obtain an initial impedance of the wick prior to a first atomization mode;
determine the initial impedance is not within a predetermined range of impedance measurements; and
prevent the first atomization mode.
15. An atomizer, comprising:
a cartridge configured to hold a medication in a fluid;
an atomizer system configured to atomize the fluid into a vapor for inhalation by a user;
a biosensor including:
a PPG circuit that emits light at a plurality of wavelengths directed to skin tissue of a user and generates a plurality of spectral responses around the plurality of wavelengths from light reflected from the skin tissue of the user;
a processing circuit configured to:
obtain a concentration level of the medication in blood flow of the user using the plurality of spectral responses; and
control the atomizer system to increase or decrease atomization of the vapor in response to the concentration level of the medication in the blood flow of the user.
16. The atomizer of claim 15 , wherein the processing circuit is further configured to:
generate an alert in response to the concentration level of the medication reaching a predetermined threshold.
17. The atomizer of claim 16 , wherein the processing circuit is further configured to:
detect an unsafe level of the concentration level of the medication in the blood flow of the user; and
deactivate operation of the atomizer.
18. The atomizer of claim 16 , wherein the processing circuit is further configured to:
determine vitals of the user using the plurality of spectral responses, wherein the vitals include a respiratory rate, a heart rate and a blood oxygen level.
19. The atomizer of claim 16 , wherein the processing circuit is further configured to:
determine a respiratory rate of the user using one or more of the plurality of spectral responses;
determine an inhalation period and exhalation period from the respiration rate; and
control the atomizer system to increase atomization of the vapor during the inhalation period and decrease atomization of the vapor during the exhalation period.
20. The atomizer of claim 16 , wherein the PPG circuit is further configured to:
generate a first spectral response of the plurality of spectral responses around a first wavelength of light reflected from the skin tissue of the user;
generate a second spectral response of the plurality of spectral responses around a second wavelength of light reflected from the skin tissue of the user;
a processing circuit configured to:
obtain a value L λ1 using the first spectral response, wherein the value L λ1 isolates the first spectral response due to pulsating blood flow;
obtain a value L λ2 using the second spectral response, wherein the value L λ2 isolates the second spectral response due to pulsating blood flow;
obtain a value R λ1,λ2 from a ratio of the value L λ1 and the value L λ2 ;
determine a concentration level of the medication in the pulsating blood flow from the value R λ1,λ2 and a calibration.
21. The atomizer of claim 15 , wherein the biosensor is integrated with the atomizer or a separate device in communication with the atomizer.
22. The biosensor of claim 15 , wherein the processing circuit is further configured to:
determine a concentration level of nitric oxide (NO) in blood flow of the user from at least one of the plurality of spectral responses, wherein the at least one of the plurality of spectral responses is obtained at a wavelength with a high absorption coefficient for NO; and
generate an alert in response to the concentration level of the NO reaching a predetermined threshold.
23. The biosensor of claim 22 , wherein the processing circuit is further configured to:
determine a concentration level of glucose in blood flow of the user using the at least one of the plurality of spectral responses obtained at a wavelength with a high absorption coefficient for NO; and
generate an alert in response to the concentration level of the glucose reaching a predetermined threshold.
24. The biosensor of claim 23 , wherein the processing circuit is further configured to:
monitor an insulin response using the at least one of the plurality of spectral responses obtained at a wavelength with a high absorption coefficient for NO.
25. The biosensor of claim 22 , wherein the wavelength with the high absorption coefficient for NO includes a wavelength of approximately 390 nm.
26. The biosensor of claim 16 , wherein the atomizer further includes a mask to deliver the vaper through the nose and mouth.
27. An atomizer, comprising:
a cartridge configured to hold a fluid;
an atomizer system configured to atomize the fluid in the cartridge into a vapor for inhalation;
a biosensor including:
a PPG circuit that emits light at a plurality of wavelengths directed to skin tissue of a user and generates a plurality of spectral responses around the plurality of wavelengths from light reflected from the skin tissue of the user;
a processing circuit configured to:
obtain a concentration level of a substance in blood flow of the user using the plurality of spectral responses; and
control the atomizer system to increase or decrease the atomization of the fluid in response to the concentration level of the substance in the blood flow of the user.
28. The atomizer of claim 27 , wherein the processing circuit is further configured to determine vitals of the user using the plurality of spectral responses, wherein the vitals include a respiratory rate, a heart rate and a blood oxygen level.
29. The atomizer of claim 27 , wherein the PPG circuit is further configured to:
generate a first spectral response of the plurality of spectral responses around a first wavelength of light reflected from the skin tissue of the user;
generate a second spectral response of the plurality of spectral responses around a second wavelength of light reflected from the skin tissue of the user;
a processing circuit configured to:
obtain a value L λ1 using the first spectral response, wherein the value L λ1 isolates the first spectral response due to pulsating blood flow;
obtain a value L λ2 using the second spectral response, wherein the value L λ2 isolates the second spectral response due to pulsating blood flow;
obtain a value R λ1,λ2 from a ratio of the value L λ1 and the value L λ2 ;
determine the concentration level of the substance in the blood flow from the value R λ1,λ2 and a calibration.
30. The atomizer of claim 29 , wherein the concentration level of a substance includes a blood nicotine level and wherein the first wavelength of light reflected from the skin tissue of the user includes a wavelength with a high absorption coefficient of blood nicotine at approximately 260 nm.